The median survival was 36.70 months for the amiodarone users and 24.48 months for the non-amiodarone users; however, the crude HR for the amiodarone users (0.83, 95% CI: 0.66–1.04, p = 0.11) did not reach statistical significance ( Table 2 ).
← all excerpts
Improved Survival in Hepatocellular Carcinoma Patients with Cardiac Arrhythmia by Amiodarone Treatment through Autophagy.
1
—
—